Lauren J. Rogak

8.1k citations

47 papers · 3.4k indexed · 1 hit paper · h-index 22

Oncology top 1%
Public Health, Environmental and Occupational Health top 1%
Pediatrics, Perinatology and Child Health top 1%
Pulmonary and Respiratory Medicine top 5%
Economics and Econometrics top 2%

Co-authors: Ethan Basch Antonia V. Bennett Thomas M. Atkinson Amylou C. Dueck Deborah Schrag Laura Sit Howard I. Scher Mark G. Kris
Topics: Cancer survivorship and care (19 papers)Health Systems, Economic Evaluations, Quality of Life (12 papers)Economic and Financial Impacts of Cancer (8 papers)
Cited by: Oncology Pediatrics, Perinatology and Child Health Public Health, Environmental and Occupational Health
Journals: Journal of Clinical Oncology Annals of Oncology Quality of Life Research
Partner nations: United States Australia

In The Last Decade

Lauren J. Rogak

46 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial

2015 1.7k citations Ethan Basch, Allison M. Deal et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Lauren J. Rogak

Since Specialization

Citations

This map shows the geographic impact of Lauren J. Rogak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauren J. Rogak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauren J. Rogak more than expected).

Fields of papers citing papers by Lauren J. Rogak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauren J. Rogak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauren J. Rogak. The network helps show where Lauren J. Rogak may publish in the future.

Co-authorship network of co-authors of Lauren J. Rogak

This figure shows the co-authorship network connecting the top 25 collaborators of Lauren J. Rogak. A scholar is included among the top collaborators of Lauren J. Rogak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauren J. Rogak. Lauren J. Rogak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®) 2024 ·Quality of Life Research ·Minji K. Lee,Sandra A. Mitchell,Ethan Basch,Gina L. Mazza,Blake Langlais,Gita Thanarajasingam,Brenda Ginos,Lauren J. Rogak,(unknown),Jennifer Jansen,Allison M. Deal,Philip Carr,Victoria Blinder,Mattias Jönsson,Gita N. Mody,Tito R. Mendoza,Antonia V. Bennett,Deborah Schrag,Amylou C. Dueck	2
2	Impact of gender representativeness in online symptom survey and clinical trial participation among patients with myeloproliferative neoplasms 2024 ·Leukemia & lymphoma ·Blake Langlais,Amylou C. Dueck,Heidi Kosiorek,Carolyn Mead‐Harvey,(unknown),Lauren J. Rogak,John Mascarenhas,Ruben A. Mesa,Krisstina Gowin,(unknown),Robyn M. Scherber,Bridget K. Marcellino,Ronald Hoffman,Gina L. Mazza	3
3	Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall period 2023 ·Quality of Life Research ·Minji K. Lee,Ethan Basch,Sandra A. Mitchell,Lori M. Minasian,Blake Langlais,Gita Thanarajasingam,Brenda Ginos,Lauren J. Rogak,Tito R. Mendoza,Antonia V. Bennett,Deborah Schrag,Gina L. Mazza,Amylou C. Dueck	8
4	An Exploratory Analysis of the “Was It Worth It?” Questionnaire as a Novel Metric to Capture Patient Perceptions of Cancer Treatment 2022 ·Value in Health ·Gita Thanarajasingam,Ethan Basch,Carolyn Mead‐Harvey,Antonia V. Bennett,Gina L. Mazza,Gisela Schwab,Jessica Roydhouse,Lauren J. Rogak,Amylou C. Dueck	12
5	Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2 2021 ·Quality of Life Research ·Gina L. Mazza,M. Petersen,Brenda Ginos,Blake Langlais,(unknown),Mrinal M. Gounder,Michelle R. Mahoney,(unknown),Gary K. Schwartz,Lauren J. Rogak,Gita Thanarajasingam,Ethan Basch,Amylou C. Dueck	3
6	Evaluating Treatment Tolerability Using the Toxicity Index With Patient-Reported Outcomes Data 2021 ·Journal of Pain and Symptom Management ·Blake Langlais,Gina L. Mazza,Gita Thanarajasingam,Lauren J. Rogak,Brenda Ginos,(unknown),Howard I. Scher,Gisela Schwab,Patricia A. Ganz,Ethan Basch,Amylou C. Dueck	15
7	Quality of life in long-term survivors of advanced melanoma treated with checkpoint inhibitors 2020 ·Journal for ImmunoTherapy of Cancer ·(unknown),Michael A. Postow,Jessica A. Lavery,Shrujal S. Baxi,Niloufer Khan,Jun J. Mao,Lauren J. Rogak,Robert Sidlow,Bridgette Thom,(unknown),Deborah Korenstein	34
8	Differential effects of an electronic symptom monitoring intervention based on the age of patients with advanced cancer 2020 ·Annals of Oncology ·Ryan David Nipp,Nora Horick,Allison M. Deal,Lauren J. Rogak,Charn‐Xin Fuh,Joseph A. Greer,Amylou C. Dueck,Ethan Basch,Jennifer S. Temel,Areej El‐Jawahri	30
9	Software for Administering the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events: Usability Study 2018 ·JMIR Human Factors ·Martin W. Schoen,Ethan Basch,Lori L. Hudson,Arlene E. Chung,Tito R. Mendoza,Sandra A. Mitchell,Diane St. Germain,(unknown),Laura Sit,Lauren J. Rogak,(unknown),(unknown),Bryce B. Reeve,Maria Fawzy,Nrupen A. Bhavsar,Charles S. Cleeland,Deborah Schrag,Amylou C. Dueck,Amy P. Abernethy	19
10	Application of a Bayesian graded response model to characterize areas of disagreement between clinician and patient grading of symptomatic adverse events 2018 ·Journal of Patient-Reported Outcomes ·Thomas M. Atkinson,Bryce B. Reeve,Amylou C. Dueck,Antonia V. Bennett,Tito R. Mendoza,Lauren J. Rogak,Ethan Basch,Yuelin Li	3
11	Exploring differences in adverse symptom event grading thresholds between clinicians and patients in the clinical trial setting 2017 ·Journal of Cancer Research and Clinical Oncology ·Thomas M. Atkinson,Lauren J. Rogak,(unknown),Sean J. Ryan,Mary Shaw,(unknown),Antonia V. Bennett,Ethan Basch,Yuelin Li	31
12	Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) 2016 ·Health and Quality of Life Outcomes ·Antonia V. Bennett,Amylou C. Dueck,Sandra A. Mitchell,Tito R. Mendoza,Bryce B. Reeve,Thomas M. Atkinson,Kathleen M. Castro,Andrea Denicoff,Lauren J. Rogak,Jay K. Harness,James D. Bearden,Donna Bryant,Robert D. Siegel,Deborah Schrag,Ethan Basch	94
13	Linguistic validation of the Spanish version of the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) 2016 ·Supportive Care in Cancer ·(unknown),Benjamin Arnold,Sandra A. Mitchell,(unknown),Tito R. Mendoza,Lauren J. Rogak,(unknown),Gordon Willis,(unknown),Suzanne C. Lechner,Frank J. Penedo,Jay K. Harness,Ethan Basch	28
14	Phase II Study of a Non-Platinum–Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas 2016 ·Journal of Thoracic Oncology ·M. Catherine Pietanza,Matthew D. Hellmann,John J. Fiore,Stephanie Smith–Marrone,Ethan Basch,Lawrence H. Schwartz,Michelle S. Ginsberg,(unknown),(unknown),Mary Shaw,Lauren J. Rogak,Alex Lash,Patrick Hilden,Mark G. Kris	2
15	Cognitive interviewing of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) 2013 ·Quality of Life Research ·(unknown),Jennifer L. Hay,Thomas M. Atkinson,Bryce B. Reeve,Sandra A. Mitchell,Tito R. Mendoza,Gordon Willis,Lori M. Minasian,Steven B. Clauser,Andrea Denicoff,Ann M. O’Mara,Alice Chen,Antonia V. Bennett,Diane Β. Paul,Joshua J. Gagne,Lauren J. Rogak,Laura Sit,Vish Viswanath,Deborah Schrag,Ethan Basch	121
16	Feasibility of Long-Term Patient Self-Reporting of Toxicities From Home via the Internet During Routine Chemotherapy 2013 ·Journal of Clinical Oncology ·Timothy J. Judson,Antonia V. Bennett,Lauren J. Rogak,Laura Sit,Allison Barz Leahy,Mark G. Kris,(unknown),Howard I. Scher,(unknown),Deborah Schrag,Ethan Basch	115
17	Measurement of Affective and Activity Pain Interference Using the Brief Pain Inventory (BPI): Cancer and Leukemia Group B 70903 2012 ·Pain Medicine ·Thomas M. Atkinson,Susan Halabi,Antonia V. Bennett,Lauren J. Rogak,Laura Sit,Yuelin Li,Ellen B. Kaplan,Ethan Basch,(unknown)	20
18	Validity and reliability of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). 2012 ·Journal of Clinical Oncology ·Amylou C. Dueck,Tito R. Mendoza,Sandra A. Mitchell,Bryce B. Reeve,Kathleen M. Castro,Andrea Denicoff,Ann M. O’Mara,Lauren J. Rogak,Steven B. Clauser,Donna Bryant,Theresa A. Gillis,James D. Bearden,Robert D. Siegel,Jay K. Harness,Diane Β. Paul,Charles S. Cleeland,Jeff A. Sloan,Deborah Schrag,Lori M. Minasian,Ethan Basch	9
19	Reliability of adverse symptom event reporting by clinicians 2011 ·Quality of Life Research ·Thomas M. Atkinson,Yuelin Li,Charles W. Coffey,Laura Sit,Mary Shaw,(unknown),Antonia V. Bennett,M. Fruscione,Lauren J. Rogak,Jennifer L. Hay,Mithat Gönen,Deborah Schrag,Ethan Basch	168
20	Substance Abuse in Cancer Pain 2010 ·Current Pain and Headache Reports ·(unknown),Lauren J. Rogak,Steven D. Passik	56

About Lauren J. Rogak

Lauren J. Rogak is a scholar working on Oncology, Statistics and Probability and Anesthesiology and Pain Medicine, having authored 47 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cancer survivorship and care (19 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers) and Economic and Financial Impacts of Cancer (8 papers). The work is most often cited by research in Oncology (2.1k citations), Pediatrics, Perinatology and Child Health (721 citations) and Public Health, Environmental and Occupational Health (1.0k citations). Lauren J. Rogak has collaborated with scholars based in United States and Australia. Frequent co-authors include Ethan Basch, Antonia V. Bennett, Thomas M. Atkinson, Amylou C. Dueck, Deborah Schrag, Laura Sit, Howard I. Scher, Mark G. Kris, M. Fruscione and Allison Barz Leahy. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and Quality of Life Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact